Key features and details
- Rabbit polyclonal to LRIG3
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Product nameAnti-LRIG3 antibody
See all LRIG3 primary antibodies
DescriptionRabbit polyclonal to LRIG3
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Human
Synthetic peptide corresponding to Human LRIG3. (Near the C terminal; NP_700356).
Database link: Q6UXM1
- Human esophagus cancer tissue.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab197989 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/25 - 1/100.|
FunctionMay play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1.
Tissue specificityWidely expressed.
Sequence similaritiesContains 3 Ig-like C2-type (immunoglobulin-like) domains.
Contains 15 LRR (leucine-rich) repeats.
Contains 1 LRRCT domain.
Contains 1 LRRNT domain.
Cellular localizationCell membrane. Cytoplasmic vesicle membrane. Detected in cytoplasmic vesicles when coexpressed with ERBB4.
- Information by UniProt
- Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody
- Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody
- LIG-3 antibody
ab197989 has been referenced in 1 publication.
- Cheng F et al. The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. Front Oncol 9:447 (2019). PubMed: 31245283